Effective treatment of neurogenic detrusor overactivity in multiple sclerosis patients using desmopressin and mirabegron.
Title | Effective treatment of neurogenic detrusor overactivity in multiple sclerosis patients using desmopressin and mirabegron. |
Publication Type | Journal Article |
Year of Publication | 2017 |
Authors | Zachariou, A., Filiponi M., Baltogiannis D., Giannakis J., Dimitriadis F., Tsounapi P., Takenaka A., & Sofikitis N. |
Journal | Can J Urol |
Volume | 24 |
Issue | 6 |
Pagination | 9107-9113 |
Date Published | 2017 Dec |
ISSN | 1195-9479 |
Keywords | Acetanilides, Adrenergic beta-3 Receptor Agonists, Adult, Antidiuretic Agents, Deamino Arginine Vasopressin, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Multiple Sclerosis, Muscarinic Antagonists, Retreatment, Solifenacin Succinate, Thiazoles, Urinary Bladder, Neurogenic, Urinary Bladder, Overactive, Urinary Incontinence, Urination |
Abstract | INTRODUCTION: Multiple sclerosis (MS) is the commonest progressive neurological disease affecting young people. With advancing disease, management of neurogenic detrusor overactivity (NDO) based on antimuscarinics may prove inadequate and if based on botulinum toxin, may necessitate clean intermittent self-catheterization. The aim of the study was to evaluate the effectiveness of combined mirabegron and desmopressin administration in the treatment of NDO in patients with MS. |
Alternate Journal | Can J Urol |
PubMed ID | 29260636 |